← Leaderboards
Robert J Vassar
Northwestern University
$28,822,218
Attributed
$34,607,873
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,254,285 · 19
By mechanism
P30$26,364,262 · 3
RF1$14,952,293 · 5
R01$9,912,064 · 4
T32$4,249,090 · 1
R21$856,133 · 2
R56$764,709 · 1
Top collaborators
- John F Disterhoft4 shared
- Katherine R. Sadleir4 shared
- Sandra Weintraub4 shared
- Constance L Cepko2 shared
- Jun Huang1 shared
- Luisa Iruela-Arispe1 shared
Most similar at Northwestern University
Same institution · by research overlap
- Dominic Edward Fullenkamp$779,360
- Luisa Iruela-Arispe$34,850,245
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseDementiaBrainNeuronsAmyloid Beta-ProteinSenile PlaquesAmyloidIn VivoGenerationsNerve DegenerationCleaved CellPharmaceutical PreparationsInhibitor/AntagonistBiochemicalBeta-Site App Cleaving Enzyme 1AgingPathway InteractionsAdverse EffectsMouse ModelCellsEnzymesInsightTherapeutic Target
Grant awards (65)
NORTHWESTERN Alzheimer's Disease Research Center$3,154,561
P30 · FY2025 · AG · contact PI
Exploring annexin A6 for the prevention of dystrophic neurites and tau seeding and spreading in Alzheimer's disease$735,953
R01 · FY2025 · AG · contact PI
In Vivo Production of CAR-Microglia for Treating Alzheimerâs Disease$613,571
R61 · FY2025 · AG
Administrative Core$529,314
P30 · FY2025 · AG · contact PI
Predoctoral and Postdoctoral Training Program in Aging and Dementia$517,386
T32 · FY2025 · AG · contact PI
Vasculo-neuronal pathophysiological interface in Alzheimerâs and Atherosclerosis$4,815,513
RF1 · FY2024 · NS
NORTHWESTERN Alzheimer's Disease Research Center$3,443,521
P30 · FY2024 · AG · contact PI
Exploring annexin A6 for the prevention of dystrophic neurites and tau seeding and spreading in Alzheimer's disease$765,973
R01 · FY2024 · AG · contact PI
The Role of RNA Binding Protein Networks in Tauopathy and Related Dementia$735,836
R01 · FY2024 · AG · contact PI
Administrative Core$570,594
P30 · FY2024 · AG · contact PI
Predoctoral and Postdoctoral Training Program in Aging and Dementia$528,090
T32 · FY2024 · AG · contact PI
NORTHWESTERN Alzheimer's Disease Research Center$3,443,521
P30 · FY2023 · AG · contact PI
Mechanisms of Angiotensin I Converting Enzyme in Alzheimer's disease$2,231,406
RF1 · FY2023 · AG · contact PI
Administrative Core$573,183
P30 · FY2023 · AG · contact PI
Predoctoral and Postdoctoral Training Program in Aging and Dementia$497,803
T32 · FY2023 · AG · contact PI
NORTHWESTERN Alzheimer's Disease Research Center$3,443,521
P30 · FY2022 · AG · contact PI
Administrative Core$570,594
P30 · FY2022 · AG · contact PI
Predoctoral and Postdoctoral Training Program in Aging and Dementia$490,748
T32 · FY2022 · AG · contact PI
Northwestern ADRC Non competing supplement application$288,960
P30 · FY2022 · AG · contact PI
NORTHWESTERN Alzheimer's Disease Research Center$3,319,145
P30 · FY2021 · AG · contact PI
Administrative Core$474,165
P30 · FY2021 · AG · contact PI
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIA$464,923
T32 · FY2021 · AG · contact PI
The Role of RNA Binding Protein Networks in Tauopathy and Related Dementia$3,090,198
RF1 · FY2020 · AG · contact PI
Alzheimer's Disease Core Center$2,415,841
P30 · FY2020 · AG · contact PI
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIA$458,080
T32 · FY2020 · AG
Alzheimer's Disease Core Center$2,415,841
P30 · FY2019 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$1,975,000
RF1 · FY2019 · AG · contact PI
RNA binding protein networks in tau pathogenesis$764,709
R56 · FY2019 · AG · contact PI
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIA$440,333
T32 · FY2019 · AG
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$316,725
R01 · FY2019 · AG · contact PI
A test of the calcium hypothesis of Alzheimers disease$276,500
R21 · FY2019 · AG · contact PI
Gene Therapy for Alzheimer's Disease$181,198
R21 · FY2019 · AG
Molecular and cellular mechanisms of the UNC5C netrin receptor in Alzheimer's disease pathogenesis$2,840,176
RF1 · FY2018 · AG · contact PI
Alzheimer's Disease Core Center$1,721,501
P30 · FY2018 · AG · contact PI
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIA$432,527
T32 · FY2018 · AG
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$316,725
R01 · FY2018 · AG · contact PI
Gene Therapy for Alzheimer's Disease$240,435
R21 · FY2018 · AG
A test of the calcium hypothesis of Alzheimers disease$158,000
R21 · FY2018 · AG · contact PI
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIA$419,200
T32 · FY2017 · AG
BACE1 as a Therapeutic Target for Alzheimer's Disease$316,725
R01 · FY2017 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$316,725
R01 · FY2017 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$316,725
R01 · FY2016 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$316,725
R01 · FY2016 · AG · contact PI
2nd Kloster Seeon Meeting on BACE Proteases in Health and Disease$34,000
R13 · FY2016 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$316,725
R01 · FY2015 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$307,223
R01 · FY2015 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$316,725
R01 · FY2014 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$316,725
R01 · FY2013 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$291,457
R01 · FY2012 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$291,516
R01 · FY2011 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$288,673
R01 · FY2011 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$303,344
R01 · FY2010 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$300,325
R01 · FY2010 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$306,465
R01 · FY2009 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$302,756
R01 · FY2009 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$304,794
R01 · FY2008 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$302,756
R01 · FY2008 · AG · contact PI
Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimer's Disease$321,685
R01 · FY2007 · AG · contact PI
ASTROCYTIC BACE1 EXPRESSION AND BETA-AMYLOID PEPTIDE GENERATION$308,608
P01 · FY2007 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$282,321
R01 · FY2007 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$290,753
R01 · FY2006 · AG · contact PI
ASTROCYTIC BACE1 EXPRESSION AND BETA-AMYLOID PEPTIDE$199,555
P01 · FY2006 · AG · contact PI
BACE1 as a Therapeutic Target for Alzheimer's Disease$297,750
R01 · FY2005 · AG
BACE1 as a Therapeutic Target for Alzheimer's Disease$309,875
R01 · FY2004 · AG
BACE1 as a Therapeutic Target for Alzheimer's Disease$322,084
R01 · FY2003 · AG